1 Projects | 1 Researchers | $584,817 Invested
2023
Amsterdam UMC, Universiteit van Amsterdam
Charlotte Teunissen
acTau-174 as a novel biomarker of tau pathology in frontotemporal dementia
Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Charlotte Teunissen
acTau-174 as a novel biomarker of tau pathology in frontotemporal dementia